Skip to Content
Merck
  • PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway.

PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway.

Molecular biology of the cell (2012-12-18)
Christine Kienzle, Stephan A Eisler, Julien Villeneuve, Tilman Brummer, Monilola A Olayioye, Angelika Hausser
ABSTRACT

Before entering mitosis, the stacks of the Golgi cisternae are separated from each other, and inhibiting this process delays entry of mammalian cells into mitosis. Protein kinase D (PKD) is known to be involved in Golgi-to-cell surface transport by controlling the biogenesis of specific transport carriers. Here we show that depletion of PKD1 and PKD2 proteins from HeLa cells by small interfering RNA leads to the accumulation of cells in the G2 phase of the cell cycle and prevents cells from entering mitosis. We further provide evidence that inhibition of PKD blocks mitotic Raf-1 and mitogen-activated protein kinase kinase (MEK) activation, and, as a consequence, mitotic Golgi fragmentation, which could be rescued by expression of active MEK1. Finally, Golgi fluorescence recovery after photobleaching analyses demonstrate that PKD is crucial for the cleavage of the noncompact zones of Golgi membranes in G2 phase. Our findings suggest that PKD controls interstack Golgi connections in a Raf-1/MEK1-dependent manner, a process required for entry of the cells into mitosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
CID755673, ≥98% (HPLC), powder